PAVmed Inc. (PAVM)

PAVmed Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1.02	3	2.45	0.38	0.5	-
Revenue Growth (YoY)	-73.36%	22.14%	550.40%	-24.60%	-	-
Cost of Revenue	1.51	4.84	6.42	3.61	0.59	-
Gross Profit	-0.49	-1.85	-3.97	-3.24	-0.09	-
Selling, General & Admin	22.43	36.15	48.53	60.73	34.32	12.39
Research & Development	3.93	5.93	14.28	25.34	19.85	10.96
Operating Expenses	26.44	42.64	64.83	87.85	54.31	23.35
Operating Income	-26.93	-44.49	-68.8	-91.09	-54.39	-23.35
Interest Expense	-0.03	-0.05	-0.59	-1.28	-	-0.05
Interest & Investment Income	0.09	0.25	0.51	0.17	-	-
Other Non Operating Income (Expenses)	10.82	4.42	-7.6	-4.33	1.68	-5.99
EBT Excluding Unusual Items	-16.05	-39.86	-76.48	-96.53	-52.71	-29.39
Gain (Loss) on Sale of Investments	10.89	0.53	-	-	-	-
Gain (Loss) on Sale of Assets	72.29	72.29	1	-	-	-
Other Unusual Items	1.02	-4.54	-3.78	-6.71	-3.42	-6.5
Pretax Income	68.15	28.43	-79.26	-103.24	-56.13	-35.89
Earnings From Continuing Operations	68.15	28.43	-79.26	-103.24	-56.13	-35.89
Minority Interest in Earnings	4.72	11.36	15.09	14.26	5.78	1.61
Net Income	72.88	39.79	-64.18	-88.98	-50.35	-34.28
Preferred Dividends & Other Adjustments	2.83	7.83	2.1	0.28	0.28	0.29
Net Income to Common	70.05	31.97	-66.27	-89.26	-50.63	-34.56
Shares Outstanding (Basic)	13	10	7	6	5	3
Shares Outstanding (Diluted)	88	65	7	6	5	3
Shares Change (YoY)	955.33%	802.87%	21.78%	14.91%	63.42%	57.07%
EPS (Basic)	5.30	3.30	-9.16	-15.03	-9.80	-10.93
EPS (Diluted)	0.83	0.50	-9.16	-15.03	-9.80	-10.93
Free Cash Flow	-11.57	-33.61	-52.28	-72.53	-42.06	-21.97
Free Cash Flow Per Share	-0.13	-0.52	-7.23	-12.21	-8.14	-6.95
Gross Margin	-47.74%	-61.60%	-161.83%	-	-17.00%	-
Operating Margin	-2639.71%	-1485.38%	-2805.67%	-24161.01%	-10878.60%	-
Profit Margin	6867.45%	1067.31%	-2702.69%	-23677.45%	-10126.00%	-
Free Cash Flow Margin	-1134.51%	-1122.17%	-2132.06%	-19237.40%	-8412.00%	-
EBITDA	-26.55	-43.29	-65.86	-88.63	-54.17	-23.33
D&A For EBITDA	0.37	1.2	2.93	2.46	0.23	0.02
EBIT	-26.93	-44.49	-68.8	-91.09	-54.39	-23.35

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q